SEARCH

SEARCH BY CITATION

References

  • 1
    Raps M, Helmerhorst F, Fleischer K, Thomassen S, Rosendaal F, Rosing J, Ballieux B, van Vliet H. Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives. J Thromb Haemost 2012; 10: 9926.
  • 2
    Stegeman BH, Helmerhorst F, Vos HL, Rosendaal FR, van Hylckama Vlieg A. Sex hormone-binding globulin levels are not causally related wuth venous thrombosis risk inwomen not using hormonal contraceptives. J Thromb Haemost 2012; 10: 20617.
  • 3
    van Vliet HA, Frolich M, Christella M, Thomassen LG, Doggen CJ, Rosendaal FR, Rosing J, Helmerhorst FM. Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens. Hum Reprod 2005; 20: 5638.
  • 4
    Odlind V, Milsom I, Persson I, Victor A. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?Acta Obstet Gynecol Scand 2002; 81: 48290.
  • 5
    Committee for Medical Products for Human Use (CHMP). Guideline on clinical investigation of steroid contraceptives in women. 2005.